Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020233
Filing Date
2022-08-12
Accepted
2022-08-12 07:30:44
Documents
47
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20220630_10q.htm   iXBRL 10-Q 904599
2 EXHIBIT 31.1 ex_399737.htm EX-31.1 12507
3 EXHIBIT 31.2 ex_399738.htm EX-31.2 12425
4 EXHIBIT 32.1 ex_399739.htm EX-32.1 7503
10 image01.jpg GRAPHIC 4697
  Complete submission text file 0001437749-22-020233.txt   4357344

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA plxp-20220630.xsd EX-101.SCH 36049
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20220630_cal.xml EX-101.CAL 34629
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20220630_def.xml EX-101.DEF 274343
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20220630_lab.xml EX-101.LAB 272701
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20220630_pre.xml EX-101.PRE 293366
41 EXTRACTED XBRL INSTANCE DOCUMENT plxp20220630_10q_htm.xml XML 570887
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 221157821
SIC: 2834 Pharmaceutical Preparations